This company listing is no longer active
ProMIS Neurosciences Balance Sheet Health
Financial Health criteria checks 1/6
ProMIS Neurosciences has a total shareholder equity of $-6.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $4.4M and $10.6M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$3.38m |
| Equity | -US$6.18m |
| Total liabilities | US$10.61m |
| Total assets | US$4.43m |
Recent financial health updates
We're A Little Worried About ProMIS Neurosciences' (TSE:PMN) Cash Burn Rate
Oct 11
Despite Lacking Profits ProMIS Neurosciences (TSE:PMN) Seems To Be On Top Of Its Debt
Jun 23Is ProMIS Neurosciences (TSE:PMN) A Risky Investment?
Mar 07Is ProMIS Neurosciences (TSE:PMN) A Risky Investment?
Nov 19Recent updates
Financial Position Analysis
Short Term Liabilities: PMN has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: PMN has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: PMN is debt free.
Reducing Debt: PMN's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PMN has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: PMN has less than a year of cash runway if free cash flow continues to reduce at historical rates of 25.7% each year